We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OPTN market cap is 71.04M. The company's latest EPS is USD -0.2353 and P/E is -2.00.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 19.82M | 19.87M | 14.88M | 20.49M | 20.44M |
| Operating Income | -1.69M | -2.51M | -8.08M | -6.55M | -2.05M |
| Net Income | -9.29M | -9.97M | -14.07M | -7.58M | 468k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 34.63M | 49.12M | 74.65M | 76.28M | 70.99M |
| Operating Income | -96M | -87.22M | -66.45M | -55.9M | -22.75M |
| Net Income | -110.45M | -99.79M | -82.3M | -74.83M | -35.48M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 101.41M | 107.73M | 83.71M | 131.87M | 131.02M |
| Total Liabilities | 179.02M | 194.34M | 182.92M | 174.73M | 172.12M |
| Total Equity | -77.62M | -86.61M | -99.22M | -42.85M | -41.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 172.65M | 188.81M | 166.07M | 144.22M | 107.73M |
| Total Liabilities | 111.07M | 182.03M | 187.84M | 200.85M | 194.34M |
| Total Equity | 61.58M | 6.79M | -21.77M | -56.62M | -86.61M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -27.44M | -20.53M | -22.03M | -37.72M | -46.55M |
| Investing | -255k | -328k | -22k | -51k | -72k |
| Financing | 296k | 300k | 7k | 55.44M | 55.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -90.82M | -86.21M | -76.94M | -67.65M | -20.53M |
| Investing | -557k | -546k | -62k | -63k | -328k |
| Financing | 37.53M | 83.81M | 43.32M | 51.44M | 300k |
| Market Cap | 71.04M |
| Price to Earnings Ratio | -2.00 |
| Price to Sales Ratio | 1 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | -0.82 |
| Dividend Yield | - |
| Shares Outstanding | 150.83M |
| Average Volume (1 week) | 724.41k |
| Average Volume (1 Month) | 1.37M |
| 52 Week Change | -60.75% |
| 52 Week High | 2.10 |
| 52 Week Low | 0.321 |
| Spread (Intraday) | 0.01 (2.34%) |
| Company Name | OptiNose Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.optinose.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
